Detalhe da pesquisa
1.
Gastroenteropancreatic Neuroendocrine Tumors.
CA Cancer J Clin
; 68(6): 471-487, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295930
2.
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.
J Natl Compr Canc Netw
; : 1-8, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744314
3.
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Int J Cancer
; 153(1): 164-172, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891979
4.
RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab.
Oncology
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061339
5.
Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine Tumor.
J Natl Compr Canc Netw
; 20(12): 1285-1287, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509068
6.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793718
7.
Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials.
Cancer
; 127(15): 2674-2682, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857327
8.
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
Cancer
; 127(17): 3194-3201, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882143
9.
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer.
Br J Cancer
; 124(11): 1803-1808, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828254
10.
Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/Temozolomide.
Oncologist
; 26(2): 115-119, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33225478
11.
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?
Oncologist
; 26(4): 294-301, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301235
12.
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 48(11): 3408-3421, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772332
13.
Sensitivity and Specificity of the NETest: A Validation Study.
Neuroendocrinology
; 111(6): 580-585, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615553
14.
Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms.
J Natl Compr Canc Netw
; 20(1): 29-36, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433130
15.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(7): 839-868, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340212
16.
An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH).
Curr Treat Options Oncol
; 22(4): 28, 2021 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641079
17.
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.
Lancet Oncol
; 21(9): e431-e443, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888472
18.
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
Br J Cancer
; 122(9): 1309-1314, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152503
19.
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.
Oncologist
; 25(1): e48-e52, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455747
20.
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med
; 376(2): 125-135, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076709